El Cerrito, CA, United States of America

Zachary Herrera

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zachary Herrera. Retrieved from https://idiyas.com/inventor/zachary-herrera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 17.0

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Houston, TX (US) (2017)
  • El Cerrito, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Zachary Herrera

Introduction

Zachary Herrera is an accomplished inventor based in El Cerrito, CA (US). He has made significant contributions to the field of medical research, particularly in the development of GLS1 inhibitors for treating diseases such as cancer. With a total of 5 patents to his name, Herrera's work is paving the way for new therapeutic approaches.

Latest Patents

Herrera's latest patents focus on GLS1 inhibitors that are crucial for treating GLS1 mediated diseases. One of his notable patents discloses compounds and compositions useful in the treatment of these diseases, having the structure of Formula I. Additionally, he has developed methods for inhibiting GLS1 activity in human or animal subjects. Another patent presents compounds of structural Formula VIIa or VIIb, or a pharmaceutically acceptable salt thereof, which are also aimed at treating GLS1 mediated diseases.

Career Highlights

Zachary Herrera is affiliated with the University of Texas System, where he conducts his research and development work. His innovative approaches and dedication to medical science have positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Maria Emilia Di Francesco and Philip Jones, who contribute to the collaborative efforts in research and development.

Conclusion

Zachary Herrera's work in developing GLS1 inhibitors represents a significant advancement in the treatment of cancer and other diseases. His contributions to medical research continue to inspire innovation and hope for future therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…